Jason Coloma V.

Companies

• Braveheart Bio, Inc.Board member Aug 5, 2026 to now¹
• Maze Therapeutics, Inc.Board member Jan 30, 2025 to now²
• Maze Therapeutics, Inc.Chief executive officer Jan 30, 2025 to now²
• Corvus Pharmaceuticals, Inc.SVP, Chief Business Officer Jun 10, 2016 to Jun 10, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BBBraveheart Bio, Inc. BRVE913,242 shares⁴$17.6M at $19.22Aug 5, 2026
• MTMaze Therapeutics, Inc. MAZE250,717 shares⁵$7.6M at $30.36Sep 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 3, 2026Sold 129 shares at $25.77 of Maze Therapeutics, Inc.⁵
• Sep 3, 2026Sold 11,282 shares at $26.01 of Maze Therapeutics, Inc.⁵
• Sep 2, 2026Sold 1,375 shares at $27.12 of Maze Therapeutics, Inc.⁵
• Sep 2, 2026Sold 9,852 shares at $26.38 of Maze Therapeutics, Inc.⁵
• Sep 1, 2026Exercised options 50,000 shares of Maze Therapeutics, Inc.⁶
• Sep 1, 2026Sold 31,908 shares at $26.29 of Maze Therapeutics, Inc.⁶
• Sep 1, 2026Sold 2,593 shares at $26.31 of Maze Therapeutics, Inc.⁶
• Aug 3, 2026Sold 1,604 shares at $27.09 of Maze Therapeutics, Inc.⁷
• Aug 3, 2026Sold 30,304 shares at $26.71 of Maze Therapeutics, Inc.⁷
• Aug 3, 2026Sold 154 shares at $27.09 of Maze Therapeutics, Inc.⁷
• Aug 3, 2026Sold 2,439 shares at $26.71 of Maze Therapeutics, Inc.⁷
• Jul 1, 2026Sold 1,597 shares at $30.44 of Maze Therapeutics, Inc.⁸
• Jul 1, 2026Sold 30,311 shares at $29.95 of Maze Therapeutics, Inc.⁸
• Jul 1, 2026Sold 2,593 shares at $29.98 of Maze Therapeutics, Inc.⁸
• Jun 23, 2026Sold 23,865 shares at $26.05 of Maze Therapeutics, Inc.⁹
• Jun 22, 2026Sold 2,040 shares at $26.00 of Maze Therapeutics, Inc.⁹
• Jun 22, 2026Sold 1,953 shares at $26.00 of Maze Therapeutics, Inc.⁹
• Jun 1, 2026Sold 553 shares at $26.24 of Maze Therapeutics, Inc.¹⁰
• Jun 1, 2026Sold 6,090 shares at $26.20 of Maze Therapeutics, Inc.¹⁰
• May 26, 2026Sold 25,582 shares at $26.02 of Maze Therapeutics, Inc.¹¹
• May 22, 2026Sold 2,478 shares at $26.00 of Maze Therapeutics, Inc.¹¹
• May 22, 2026Sold 4,504 shares at $26.00 of Maze Therapeutics, Inc.¹¹
• May 15, 2026Sold 116 shares at $26.00 of Maze Therapeutics, Inc.¹²
• May 15, 2026Sold 1,822 shares at $26.00 of Maze Therapeutics, Inc.¹²